A New Indicator to Assess Stenosis Severity

Fractional Myocardial Mass to Assess Stenosis Severity

This study looked at the role of fractional myocardial mass (vessel-specific myocardial mass) in the assessment of stenosis physiological severity.

 

Researchers used CT angiography to study this new concept of myocardial mass subtended by a specific vessel, which could reduce anatomical-physiological mismatch.

 

The study included 463 patients with 724 lesions evaluated by multislice coronary computed tomography angiography and invasive coronary angiography with fractional flow reserve measurement (FFR).

 

Fractional myocardial mass was assessed based on arterial tree length and myocardial mass by CT.

 

FFR <0.80 was considered a functionally significant lesion and it was found in 39% of observed vessels. Fractional myocardial mass decreased consistently according to vessel caliber, which is obvious.

 

FFR <0.80 increased in direct proportion to fractional myocardial mass and inversely to angiographic minimal luminal diameter (p < 0.001).

 

Fractional myocardial mass and minimal luminal diameter showed good correlation with FFR (r=0.61) and resulted superior to stenosis diameter to predict FFR <0.80.

 

Optimal cutoff value for fractional myocardial mass/minimal luminal diameter was 29 g/mm with 75% sensitivity,   77% specificity and 77% diagnostic accuracy.

 

This relation could add information to the classical stenosis diameter to predict FFR<0.80.

 

 

Conclusion

The relation fractional myocardial mass / minimal luminal diameter could help discriminate functional compromise of vessels more accurately than anatomical stenosis. The concept of fractional myocardial mass could explain the discrepancy between anatomy and physiology.

 

Original Title: Physiological Severity of Coronary Artery Stenosis Depends on the Amount of Myocardial Mass Subtended by the Coronary Artery.

Reference: Hyung Yoon Kim et al. JACC Cardiovasc Interv. 2016 Aug 8;9(15):1548-60.

 

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....